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Travelers’ diarrhea is a major public health problem. 
From patients in whom diarrhea developed after travel to 
India, 5 enteroaggregative Escherichia coli strains carrying 
β-lactamase CTX-M-15 were identiﬁ  ed; 3 belonged to clonal 
complex sequence type 38. This β-lactamase contributes 
to the multidrug resistance of enteroaggregative E. coli, 
thereby limiting therapeutic alternatives.
T
ravelers’ diarrhea remains a major public health problem, 
causing substantial illness and disability. Almost 50% 
of patients with travelers’ diarrhea require treatment with 
antimicrobial drugs because of persistence or severity of 
signs and symptoms (1). Enteroaggregative E. coli (EAEC) 
is among the most common diarrheagenic E. coli pathotypes 
recognized (2). The ﬁ  rst-choice agents for treating EAEC 
infections are quinolones, rifaximin, azithromycin, and 
cephalosporins. However, the number of pathogenic E. 
coli strains resistant to multiple antimicrobial agents has 
increased, and resistance to third-generation cephalosporins 
(e.g., ceftazidime, ceftriaxone, or cefotaxime) associated 
with production of extended-spectrum β-lactamases (ESBLs) 
limits therapeutic options (3).
Although ESBL production has mainly been shown in 
extraintestinal E. coli infections, studies concerning effects 
of ESBLs in intestinal E. coli infections are scarce. The 
worldwide spread of CTX-M-15 type ESBLs has led these 
β-lactamases to replace TEM- and SHV-type ESBLs in 
Europe, Canada, and Asia and become one of the major 
groups of ESBLs studied. Of the different CTX-M–type 
ESBLs, CTX-M-15 has become the most widely distributed 
enzyme worldwide. It was ﬁ  rst identiﬁ  ed in an isolate from 
India in 1999 and thereafter became prevalent around 
the world (4). CTX-M-15 enhances hydrolytic activity 
against ceftazidime (5). A particular clone of CTX-M-15–
producing  E. coli, characterized by phylogenetic type 
(phylotype) B2 and sequence type 131 (ST131), seems 
to be largely responsible for international epidemics of 
CTX-M–producing E. coli (6). Sequence types (STs) are 
grouped into clonal complexes by their similarity to a 
central allelic proﬁ  le. 
ST131 is a singleton and therefore does not belong 
to a clonal complex (7). Molecular epidemiologic studies 
have suggested that the sudden increase in CTX-M-15–
producing E. coli worldwide was mainly caused by this 
single clone (ST131) and that foreign travel to high-risk 
areas, such as the Indian subcontinent, might play a partial 
role in the spread of this clone across continents (8). The 
blaCTX-M-15 gene is usually found downstream from the 
insertion sequence ISEcp1, which may be involved in the 
clone’s dissemination and expression (9). We describe 
molecular epidemiology and plasmid analyses of 5 
CTX-M-15–producing EAEC isolates from patients with 
travelers’ diarrhea who had traveled from Spain to India.
The Study 
The study included all patients with diarrhea who 
visited the Tropical Medicine Unit of Hospital Clinic in 
Barcelona, Spain, during 2005 and 2006. Patients with 
diarrhea that started during or shortly after (<5 days) a stay 
in a developing country were eligible. After the participants 
provided informed consent, clinical and epidemiologic data 
were collected. 
Among all eligible participants, infection with EAEC 
and no other enteropathogen was found for 51. Of these 
51 EAEC isolates, 5 from patients who had traveled to 
India were resistant to third-generation cephalosporins. 
Resistance phenotypes indicated ESBL production. 
MICs for antimicrobial agents and susceptibility class 
were determined by using the Clinical and Laboratory 
Standards Institute breakpoints guideline (Table 1). All 
strains were resistant to penicillins; second-, third-, and 
fourth-generation cephalosporins; and all β-lactamase–
inhibitor combinations except piperacillin/tazobactam. 
Apart from β-lactam susceptibility, the strains showed 
resistance to other classes of antimicrobial agents, such 
as  ﬂ   uoroquinolones, tetracyclines, and monobactams 
(aztreonam). Positive ampliﬁ  cation with speciﬁ  c primers 
and sequencing for the blaCTX-M-15 gene provided positive 
genotypic conﬁ  rmatory test results for ESBL production.
The epidemiologic relationships among the 5 strains 
were studied by repetitive sequence–based PCR, pulsed-
ﬁ  eld gel electrophoresis, and multilocus sequence typing 
(10,11). The PCR and pulsed-ﬁ   eld gel electrophoresis 
genomic ﬁ  ngerprinting showed that the 5 strains were not 
epidemiologically related (Figure 1). However, multilocus 
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sequence typing identiﬁ  ed 2 clonal complexes: ST38 (3 
strains) and ST10 (1 strain). The ﬁ  fth strain could not be 
classiﬁ  ed into any clonal complex (Table 2).
E. coli strains were classiﬁ  ed into phylogenetic groups 
by multiplex PCR, described by Clermont et al. (12). The 3 
strains in clonal complex ST38 belonged to the potentially 
virulent phylogenetic group D; the other 2 belonged to 
group B2 (Table 2).
A PCR method was used to detect genes encoding for 
typical EAEC virulence factors (2). These genes include 
aggA and aafA (encoding for adhesions); aap (for dispersin); 
aatA (for TolC); aggR (for regulation of aggregation); astA, 
set1A, and sen (for toxins), fyuA (for iron recruitment); agn43 
(for antigen 43); and genes encoding for serine protease 
autotransporter toxins such as pet and sat. Gene aatA was 
detected in the 5 strains, whereas aap, aggR, and aggA had 
positive ampliﬁ  cation for only 2 of the strains belonging to 
ST38. The other genes detected are shown in Table 2. EAEC 
was also identiﬁ  ed by typical adherence to HEp-2 cells.
To determine the genetic environment of the blaCTX-M-15 
gene, we designed an inverse PCR. We designed the primers 
by studying the gene sequence and were directed outside 
the gene. The ISEcp1 insertion sequence was upstream 
from the blaCTX-M-15 gene, which was also conﬁ  rmed by PCR 
of the speciﬁ  c insertion sequence. To conﬁ  rm the possible 
relationship between ISEcp1 and the resistance blaCTX-M-15 
gene, we conducted a PCR with the forward primer for the 
ISEcp1 and the reverse primer for the blaCTX-M-15 gene.
For plasmid extraction of the 5 isolates, we used the 
method of Kado and Liu (13). Only 3 strains had plasmids 
ranging from 93 kb to 170 kb (Figure 2, panel A). To conﬁ  rm 
the absence of plasmids in the 2 strains, we conducted S1 
digestion of the strains, resolving chromosomal DNA from 
plasmidic DNA. Southern blot of this digestion showed that 
the blaCTX-M-15 gene was chromosomally located in these 2 
strains, as was the aatA gene (usually found in the plasmid 
contained in EAEC strains) (data not shown). Finally, the 
location of the blaCTX-M-15 gene in the 3 plasmid-containing 
strains was analyzed by using Southern blot from the 
plasmid extraction. The blaCTX-M-15 gene was located in a 
plasmid in the 3 strains. The size of the plasmid containing 
CTX-M-15 varied in each strain (Figure 2, panel B). 
Plasmids with speciﬁ  c known molecular weight were used 
to provide a range of the size of the plasmids studied.
Conclusions
We identiﬁ   ed several features concerning the 
molecular epidemiology of CTX-M-15–producing EAEC 
isolates in India. First, all strains belonged to phylogenetic 
groups D and B2, the 2 groups most commonly found 
with E. coli infections (14). Second, not ﬁ  nding ST131 
suggests that ST131 might not be the most common ST 
among EAEC strains from India and that clonal complex 
ST38 might play a large role in causing infectious intestinal 
diseases. Third, the blaCTX-M-15 gene is not only located in 
the plasmid but may also be in the chromosome. However, 
previous reports have shown that blaCTX-M-15 is consistently 
linked with ISEcp1, which means that the chromosomal 
location might have originated from a previous plasmid 
location that was part of either a transposon or a cassette 
within an integron (9). It is also worth noting that the size 
of the plasmids containing the blaCTX-M-15 gene was not the 
same in all strains, indicating that this gene may be located 
in different types of plasmids.
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Figure 1. Cluster analysis of the 
enteroaggregative  Escherichia 
coli strains from the pulsed-
ﬁ   eld gel electrophoresis 
ﬁ  ngerprinting.




AM PR AG P/T A/S FU FOX FZ PIM CTX CAZ GN AK TB F IMI ME AZ CIP NOR LEV TE SXT CL
HC19 R R R S R R I R R R R R S R S S S R R R R S R S
HC64 R R R S R R I R R R R S S R S S S R R R R R R S
HC67 R R R S R R I R R R I R R R S S S R R R R R R S
HC74 R R R S R R I R R R R S R R S S S R R R R R R R
HC76 R R I S R R S R I R S S S S S S S I R R R R R S
*AM, ampicillin; PR, piperacillin; AG, amoxiclavulanic acid/augmentin; P/T, piperacillin/tazobactam; A/S, ampicillin/sulbactam; FU, cefuroxime; FOX, 
cefoxitin; FZ, cefazoline; PIM, cefepime; CTX, cefotaxime; CAZ, ceftazidime; GN, gentamicin; AK, amikacin; TB, tobramycin; F, fosfomycin; IMI,  
imipenem; ME, meropenem; AZ, aztreonam; CIP, ciprofloxacin; NOR, norfloxacin; LEV, levofloxacin; TE, tetracycline; SXT, cotrimoxazole; CL, 
chloramphenicol; R, resistant; S, sensitive; I, intermediate. This evidence of widespread distribution and ﬂ  exibility 
of the blaCTX-M-15 gene highlights the need to develop 
appropriate means to control dissemination of this gene and 
associated resistance genes. Epidemiologic surveillance 
and correct use of antimicrobial agents will help prevent the 
steady increase of antimicrobial drug resistance worldwide.
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